Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Hauser

Showing results (111-120 of 266) with videos related to

Pageof 27
Sort By:
Clinical Neuropharmacology|January 30, 2023
The Clinical Development of Levodopa Inhalation PowderRobert A Hauser, Peter A LeWitt, Cheryl H Waters, et al.
Clinical Neuropharmacology|October 7, 2008
Levetiracetam for stiff-person syndrome: report of 2 patientsW Reed Shimberg, Neha B Patel, Kelly L Sullivan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 2016
Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trialDaniel Weintraub, Robert A Hauser, Jordan J Elm, et al.
Parkinsonism & Related Disorders|March 17, 2022
Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazineRobert A Hauser, Hadas Barkay, Amanda Wilhelm, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 6, 2005
Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's diseaseKelly L Sullivan, Joseph F Staffetti, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2005
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's diseaseTheresa A Zesiewicz, Kelly L Sullivan, John L Maldonado, et al.
BMC Neurology|June 9, 2016
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's diseaseRobert A Hauser, Jaroslaw Slawek, Paolo Barone, et al.
Neuropsychology|September 22, 2010
The independent influence of apathy and depression on cognitive functioning in Parkinson's diseaseLondon C Butterfield, Cynthia R Cimino, Lynn E Oelke, et al.
The International Journal of Neuroscience|September 7, 2013
Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patientsRajeev Kumar, Robert A Hauser, Joseph Mostillo, et al.
Advances in Therapy|March 10, 2022
P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson's DiseaseRobert A Hauser, Nir Giladi, Werner Poewe, et al.
Pageof 27

Showing results (111-120 of 266) with videos related to

Sort By:
Pageof 27
Clinical Neuropharmacology|January 30, 2023
The Clinical Development of Levodopa Inhalation PowderRobert A Hauser, Peter A LeWitt, Cheryl H Waters, et al.
Clinical Neuropharmacology|October 7, 2008
Levetiracetam for stiff-person syndrome: report of 2 patientsW Reed Shimberg, Neha B Patel, Kelly L Sullivan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 2016
Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trialDaniel Weintraub, Robert A Hauser, Jordan J Elm, et al.
Parkinsonism & Related Disorders|March 17, 2022
Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazineRobert A Hauser, Hadas Barkay, Amanda Wilhelm, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 6, 2005
Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's diseaseKelly L Sullivan, Joseph F Staffetti, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2005
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's diseaseTheresa A Zesiewicz, Kelly L Sullivan, John L Maldonado, et al.
BMC Neurology|June 9, 2016
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's diseaseRobert A Hauser, Jaroslaw Slawek, Paolo Barone, et al.
Neuropsychology|September 22, 2010
The independent influence of apathy and depression on cognitive functioning in Parkinson's diseaseLondon C Butterfield, Cynthia R Cimino, Lynn E Oelke, et al.
The International Journal of Neuroscience|September 7, 2013
Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patientsRajeev Kumar, Robert A Hauser, Joseph Mostillo, et al.
Advances in Therapy|March 10, 2022
P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson's DiseaseRobert A Hauser, Nir Giladi, Werner Poewe, et al.
Pageof 27